欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5020/001
药品名称Dexmedetomidine Baxter
活性成分
    • DEXMEDETOMIDINE HYDROCHLORIDE 100.0 µg/ml
剂型Concentrate for solution for infusion
上市许可持有人Baxter Holding B.V. Kobaltweg 49 3542 CE Utrecht the Netherlands
参考成员国 - 产品名称Netherlands (NL)
Dexmedetomidine Baxter 100 microgram/ml concentraat voor oplossing voor infusie
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Dexmedetomidin Baxter 100 Mikrogramm/ml Konzentrat zur Herstellung einer Infusionslösung
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
    • Germany (DE)
      Dexmedetomidin Baxter 100 Mikrogramm/ml Konzentrat zur Herstellung einer Infusionslösung
    • Sweden (SE)
    • Denmark (DK)
      Dexmedetomidine Baxter
    • Norway (NO)
      Dexmedetomidine Baxter
    • Belgium (BE)
      Dexmedetomidine Baxter 100 microgrammes/ml solution à diluer pour perfusion
    • Finland (FI)
    • Luxembourg (LU)
    • Cyprus (CY)
      Dexmedetomidine/Baxter 100mcg/ml Concentrate for solution for infusion
许可日期2021/01/07
最近更新日期2024/06/26
药物ATC编码
    • N05CM18 dexmedetomidine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase